Physician profile
Bryan A Sagray
NPI 1285861054
$1,576.22
in general payments reported to CMS, 2019-2025
20 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $355.31 | 2025 | N/A, Augment Injectable, Asnis |
| Treace Medical Concepts, INC. | $265.33 | 2025 | |
| Depuy Synthes Sales INC. | $212.34 | 2019-2025 | Motoband, Na |
| Zimmer Biomet Holdings, INC. | $151.87 | 2019 | |
| Paratek Pharmaceuticals, INC. | $103.95 | 2025 | Nuzyra |
| Amgen INC. | $76.59 | 2025 | Krystexxa |
| Abbvie INC. | $51.95 | 2025 | |
| Smith+Nephew, INC. | $43.06 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Averitas Pharma INC. | $39.43 | 2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $39.15 | 2025 | Purified Cortrophin Gel |
| Kerecis Limited | $37.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $35.01 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Vertex Pharmaceuticals Incorporated | $31.77 | 2025 | |
| Arthrosurface Incorporated | $29.54 | 2025 | Toe Motiontm |
| Mission Medical Distribution, LLC | $26.13 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $18.06 | 2025 | Licart, Tirosint, Flector |
| Pacira Pharmaceuticals Incorporated | $16.40 | 2025 | Exparel |
| Orthofix Medical, INC. | $15.01 | 2025 | Physio-Stim |
| Heron Therapeutics, INC. | $14.01 | 2025 | Zynrelef |
| Organogenesis INC. | $13.94 | 2025 | Via Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Sagray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.